Research has shown that a potential new targeted therapy for childhood brain cancer is effective in infiltrating and killing tumor cells in preclinical models tested in mice. The novel drug CT-179 was ...

Adding CT-179 to combinations of treatments may bring new efficacy to brain tumor therapy." The research teams collaborated ...

Childhood brain cancer research breakthrough could transform treatment: International study: Atlanta, Georgia Thursday, February 6, 2025, 14:00 Hrs [IST] Brain cancer is the secon ...

Children struck down with brain cancer have been given new hope with Queensland scientists hailing a breakthrough in the ...

A new study reveals that the experimental drug CT-179 targets OLIG2-positive cancer stem cells, preventing tumor recurrence in medulloblastoma. Preclinical trials show the drug crosses the blood-brain ...

Timothy Gershon, Emory University Professor The research teams collaborated with U.S. drug company, Curtana Pharmaceuticals, that developed the experimental small molecule drug, termed CT-179.

The research teams collaborated with U.S. drug company, Curtana Pharmaceuticals, that developed the experimental small molecule drug, termed CT-179. They found that the drug effectively targets ...

The research teams collaborated with US biopharmaceutical company, Curtana Pharmaceuticals, which has developed an experimental drug, CT-179. The researchers found that the drug effectively ...